Rockefeller Capital Management
BHVN

Rockefeller Capital Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Rockefeller Capital Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-21
Closed -$3K – 4455
2022
Q3 		$3K Sell
21
-26
-55% -$3.85K ﹤0.01% 3541
2022
Q2 		$6K Sell
47
-8
-15% -$1.02K ﹤0.01% 3413
2022
Q1 		$6K Sell
55
-94
-63% -$11.7K ﹤0.01% 3310
2021
Q4 		$20K Buy
+149
New +$18.9K ﹤0.01% 2660
2021
Q3 		– Sell
-13
Closed -$1K – 3983
2021
Q2 		$1K Buy
+13
New +$1.05K ﹤0.01% 3415
2021
Q1 		– Sell
-1,413
Closed -$121K – 3493
2020
Q4 		$121K Sell
1,413
-2,096
-60% -$178K ﹤0.01% 1369
2020
Q3 		$228K Buy
3,509
+757
+28% +$49.6K ﹤0.01% 998
2020
Q2 		$201K Sell
2,752
-2,232
-45% -$119K ﹤0.01% 950
2020
Q1 		$170K Hold
4,984
– – ﹤0.01% 860
2019
Q4 		$271K Buy
+4,984
New +$247K ﹤0.01% 701

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

Rockefeller Capital Management's BHVN Position: Q4 2022 in Review

Rockefeller Capital Management sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 21 shares — an estimated $3K sold.

Rockefeller Capital Management first reported a position in BHVN in Q4 2019 and held it in 10 quarters. The position peaked at $271K in Q4 2019. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Rockefeller Capital Management reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • Rockefeller Capital Management sold 21 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $3K.
  • Rockefeller Capital Management first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q4 2019 and held it in 10 quarters.
  • Rockefeller Capital Management's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $271K in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Rockefeller Capital Management's 13F filing for Q4 2022, filed 6 Mar 2023.